Cargando…

Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine

Zika virus (ZIKV), a mosquito-borne flavivirus, has attracted global attention due to its close association with congenital Zika syndrome and neurological diseases, and transmission through additional routes, such as sexual contact. Currently there are no vaccines approved for ZIKV, and thus, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xinyi, Tai, Wanbo, Zhang, Xiaolu, Zhou, Yusen, Du, Lanying, Shen, Chuanlai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963592/ https://www.ncbi.nlm.nih.gov/pubmed/31717890 http://dx.doi.org/10.3390/vaccines7040161

Ejemplares similares

Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy
por: Tai, Wanbo, et al.
Publicado: (2019)

Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
por: Wu, Yanling, et al.
Publicado: (2017)

The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation
por: George, Parakkal Jovvian, et al.
Publicado: (2020)

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
por: Du, Lanying, et al.
Publicado: (2016)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
por: López-Camacho, César, et al.
Publicado: (2020)

Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice
por: To, Albert, et al.
Publicado: (2018)

A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity
por: Gao, Yaning, et al.
Publicado: (2022)

Vaccines for the prevention against the threat of MERS-CoV
por: Du, Lanying, et al.
Publicado: (2016)

Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines
por: Endalew, Abaineh D., et al.
Publicado: (2019)

Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
por: Tai, Wanbo, et al.
Publicado: (2018)

Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity
por: Diamos, Andrew G., et al.
Publicado: (2020)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage
por: Gambino, Frank, et al.
Publicado: (2021)

Dengue virus type-3 envelope protein domain III; expression and immunogenicity
por: Fahimi, Hossein, et al.
Publicado: (2014)

Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain
por: He, Lei, et al.
Publicado: (2019)

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
por: Zhang, Naru, et al.
Publicado: (2016)

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
por: Gallichotte, Emily N., et al.
Publicado: (2019)

Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors
por: Gao, Yaning, et al.
Publicado: (2019)

Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
por: Du, Lanying, et al.
Publicado: (2009)

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice
por: Chen, Mei-Yu, et al.
Publicado: (2020)

Zika Virus Envelope Protein Domain III Produced in K. phaffii Has the Potential for Diagnostic Applications
por: Prates, John Willians Oliveira, et al.
Publicado: (2022)

Immunogenicity of a novel tetravalent dengue envelope protein domain III-based antigen in mice
por: Fahimi, Hossein, et al.
Publicado: (2018)

Immunogenic Subviral Particles Displaying Domain III of Dengue 2 Envelope Protein Vectored by Measles Virus
por: Harahap-Carrillo, Indira S., et al.
Publicado: (2015)

Production and immunogenicity of Fubc subunit protein redesigned from DENV envelope protein
por: Rathore, Abhishek Singh, et al.
Publicado: (2020)

Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal Demise
por: Tai, Wanbo, et al.
Publicado: (2019)

Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
por: Tang, Jian, et al.
Publicado: (2015)

Use of Envelope Domain III Protein for the Detection of IgG Type Antibodies Specific to Zika Virus by Indirect ELISA
por: Ndiaye, Oumar, et al.
Publicado: (2023)

Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
por: Shi, Juan, et al.
Publicado: (2023)

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2016)

Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
por: Yang, Ming, et al.
Publicado: (2017)

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
por: Chiang, Chen-Yi, et al.
Publicado: (2016)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
por: Liu, Heng, et al.
Publicado: (2012)

Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine
por: Hao, Ling, et al.
Publicado: (2020)

Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice
por: To, Albert, et al.
Publicado: (2022)

A Small-Plaque Isolate of the Zika Virus with Envelope Domain III Mutations Affect Viral Entry and Replication in Mammalian but Not Mosquito Cells
por: Jaimipuk, Thitigun, et al.
Publicado: (2022)

Production of Recombinant Zika Virus Envelope Protein by Airlift Bioreactor as a New Subunit Vaccine Platform
por: da Costa, Hernan H. M., et al.
Publicado: (2023)

A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
por: Zhao, Guangyu, et al.
Publicado: (2018)

Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III
por: Fan, Yi-Chin, et al.
Publicado: (2015)

Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine
por: Techawiwattanaboon, Teerasit, et al.
Publicado: (2022)

Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines
por: Bidokhti, Mehdi R.M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ag5ck5giaq1d7fkk0vsak6kb72